QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

AZTA

QT76Azenta, Inc.
NASDAQ·Healthcare·Medical - Instruments & Supplies·USA
Latest market price
23.31
+0.63+2.78%
OverviewShort InterestFilings
AZTAQT76Azenta, Inc.·NASDAQ
OverviewShort InterestFilings
23.31+2.78%
TA
Loading chart...
Screen all →
BDX+1.67%$143.98ALC+0.84%$64.68MDLN-1.32%$35.94WST+1.35%$327.95COO+1.32%$65.91BAX+2.58%$19.89ATR+0.28%$120.32RGEN-1.15%$132.02
Snapshot
Index-P/E-EPS (ttm)-3.96
Insider Own6.88%
Shs Outstand46.09M
Perf Week3.78%
Market Cap1.05BForward P/E37.97EPS next Y0.61Insider Trans0.02%Shs Float-Perf Month32.07%
Enterprise Value866.83MPEG0.04EPS next Q0.10Inst Own-Short Float-Perf Quarter12.99%
Income-178303329.00P/S1.75EPS this Y111.33%Inst Trans-Short Ratio-Perf Half Y-32.06%
Sales596.58MP/B0.67EPS next Y36.82%ROA-9.36%Short Interest-Perf YTD-29.92%
Book/sh33.74P/C17.12EPS next 5Y40.73%ROE-10.69%52W High41.73 -44.14%Perf Year-20.47%
Cash/sh8.27P/FCF36.40EPS past 3/5Y-ROIC-0.70%52W Low15.93 46.33%Perf 3Y-
Dividend Est.-EV/EBITDA-9.33Sales past 3/5Y2.29% 8.83%Gross Margin44.55%Volatility2.92% 3.20%Perf 5Y-
Dividend TTM-EV/Sales1.45EPS Y/Y TTM114.56%Oper. Margin-2.62%ATR (14)1.09Perf 10Y-
Dividend Ex-DateDec 02, 2021Quick Ratio2.52Sales Y/Y TTM4.19%Profit Margin-29.86%RSI (14)58.88Recom2.00
Dividend Gr. 3/5Y0.00% 0.00%Current Ratio2.83EPS Q/Q-180.00%SMA204.09%Beta1.73Target Price44.50
Payout0.00%Debt/Eq0.04Sales Q/Q1.40%SMA505.03%Rel Volume0.99Prev Close22.68
Employees3,000LT Debt/Eq0.06EarningsAug 04SMA200-18.65%Avg Volume1.19MPrice23.31
IPO DateFeb 02, 1995Option/ShortYes / YesEPS/Sales Surpr.-140.00% -2.03%Net Debt/EBITDA1.92Volume1,186,264Change2.78%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-05-26ReiteratedEvercore ISI$50 → $45
Jan-05-26ReiteratedEvercore ISI$33 → $50
Jan-05-26UpgradeEvercore ISI GroupIn Line → Outperform
Dec-19-25ReiteratedNeedhamBuy$78 → $44
Nov-25-25ReiteratedRaymond JamesOutperform$45
Oct-30-25UpgradeJefferiesHold → Buy$64 → $38
Aug-06-25UpgradeRaymond JamesMarket Perform → Outperform
Aug-05-25ReiteratedEvercore ISI$35 → $33
Dec-18-24UpgradeStephens & Co.Equal Weight → Overweight
Apr-04-24ReiteratedJefferies$64
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
9/30/2025
FY 2024
9/30/2024
FY 2023
9/30/2023
FY 2022
9/30/2022
FY 2021
9/30/2021
FY 2020
9/30/2020
FY 2019
9/30/2019
FY 2018
9/30/2018
Total Revenue597594573
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A331324319
Gross Profit266270255
Selling, General and Administrative Excl. Other247251253
Research and Development333032
Other Operating Expense110
Operating Income-15-11-30
Interest Expense000
Unusual Expense
———
Non-Operating Income (Expense)134-4-11
Net Income Before Taxes-150-7-19
Income Taxes-39-325
Consolidated Net Income-178-56-165
Net Income From Continuing Operations-10924-24
Net Income-178-56-165
EPS (Recurring)-3.95-1.22-3.09
EPS (Basic, Before Extraordinaries)-3.95-1.22-3.09
EPS (Diluted)-3.96-1.22-3.09
EBITDA-925472
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio1.802.22—
Gross Margin44.5645.4544.50
Operating Margin-2.51-1.85-5.24
Net Margin-29.82-9.43-28.80
Shares Outstanding464653
Market Capitalization1,0721,321—
Operating Lease Expense
———
Insider Trading Volume
$24.06$22.50$20.95$19.39$17.83● Close Price0.00K40.95K81.90K122.85K163.80KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Cornog William LDirectorMay 18 '26Buy16.3810,000163,80019,703May 19 12:00 AM
Cornog William LDirectorMay 20 '25Buy27.372,74875,21325,795Nov 25 12:00 AM
Cornog William LDirectorMay 19 '25Buy26.984,152112,02123,047Nov 25 12:00 AM
Cornog William LDirectorMay 16 '25Buy26.501002,65018,895Nov 25 12:00 AM
Zhou GingerSVP and GM, MultiomicsAug 12 '25Sale28.541,08530,96626,831Nov 14 12:00 AM
Pirogova OlgaSVP and CHROAug 12 '25Sale28.541,08530,96618,288Nov 14 12:00 AM
Marotta JohnPresident and CEOJun 02 '25Buy25.991,00025,990107,296Nov 14 12:00 AM
Malus Alan JDirectorMay 30 '25Buy26.6512,000319,80017,035Nov 14 12:00 AM
Marotta JohnPresident and CEOSep 10 '25Sale29.413169,294105,980Sep 12 12:00 AM
Lin Lawrence Y.EVP, CFO and TreasurerAug 11 '25Buy27.962,50069,90046,013Aug 12 12:00 AM
Hughes ViolettaVP, Chief Accounting OfficerFeb 03 '25Sale52.9731716,7919,603Feb 04 12:00 AM
Zhou GingerSVP and General Manager, GenomJan 31 '25Buy45.8841719,13227,916Feb 04 12:00 AM
Zhou GingerSVP and General Manager, GenomNov 19 '24Sale40.0749119,67427,499Nov 21 12:00 AM
Wang David DongSVP & GM, SMSNov 19 '24Sale40.0734813,94424,114Nov 21 12:00 AM
Cueto HermanEVP, Chief Financial OfficerNov 19 '24Sale40.0771228,53023,892Nov 21 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR